• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病态肥胖患者肝脏形态与临床及生化检查结果的关系

Relationship between hepatic morphology and clinical and biochemical findings in morbidly obese patients.

作者信息

Manes J L, Taylor H B, Starkloff G B

出版信息

J Clin Pathol. 1973 Oct;26(10):776-83. doi: 10.1136/jcp.26.10.776.

DOI:10.1136/jcp.26.10.776
PMID:4750460
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC477881/
Abstract

This study was undertaken to determine the interrelations between clinico-biochemical parameters and hepatic morphology in markedly obese patients. One hundred and sixty-six women and 52 men comprise this series. There was a statistically significant association of carbohydrate metabolism disturbance with increasing age and corpulence and, in women, with hyperuricaemia and morphological alterations of the liver. Menstrual irregularities also correlated well with hepatic morphology. The livers frequently exhibited steatosis, but other morphological changes were mild. Compared with women, men had higher triglyceride values, more severe hepatic involvement, and poorer correlation of carbohydrate disturbances with hepatic histology. The results indicate a central role of the impaired carbohydrate utilization in the biochemical and hepatic alterations of obesity.

摘要

本研究旨在确定明显肥胖患者临床生化参数与肝脏形态之间的相互关系。该系列研究包括166名女性和52名男性。碳水化合物代谢紊乱与年龄增长、肥胖相关,在女性中还与高尿酸血症及肝脏形态改变存在统计学上的显著关联。月经不调也与肝脏形态密切相关。肝脏常表现为脂肪变性,但其他形态学改变较轻。与女性相比,男性甘油三酯值更高,肝脏受累更严重,碳水化合物紊乱与肝脏组织学的相关性更差。结果表明,碳水化合物利用受损在肥胖的生化和肝脏改变中起核心作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c0a/477881/086a737d1db9/jclinpath00120-0053-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c0a/477881/0677ec5e73f3/jclinpath00120-0051-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c0a/477881/a4e562df89ae/jclinpath00120-0051-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c0a/477881/801e50ee3761/jclinpath00120-0052-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c0a/477881/735e39f98657/jclinpath00120-0052-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c0a/477881/4d30e41e577f/jclinpath00120-0052-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c0a/477881/086a737d1db9/jclinpath00120-0053-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c0a/477881/0677ec5e73f3/jclinpath00120-0051-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c0a/477881/a4e562df89ae/jclinpath00120-0051-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c0a/477881/801e50ee3761/jclinpath00120-0052-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c0a/477881/735e39f98657/jclinpath00120-0052-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c0a/477881/4d30e41e577f/jclinpath00120-0052-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c0a/477881/086a737d1db9/jclinpath00120-0053-a.jpg

相似文献

1
Relationship between hepatic morphology and clinical and biochemical findings in morbidly obese patients.病态肥胖患者肝脏形态与临床及生化检查结果的关系
J Clin Pathol. 1973 Oct;26(10):776-83. doi: 10.1136/jcp.26.10.776.
2
Relationship between uric acid and hepatic steatosis among Koreans.尿酸与韩国人群肝脂肪变性的关系。
Diabetes Metab. 2009 Dec;35(6):447-51. doi: 10.1016/j.diabet.2009.04.011.
3
Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.脂肪限制和代谢因素在肥胖糖尿病小鼠脂肪变性进展为脂肪性肝炎中的作用
J Gastroenterol Hepatol. 2009 Oct;24(10):1658-68. doi: 10.1111/j.1440-1746.2009.05996.x.
4
Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.限制蛋氨酸摄入可防止瘦素缺乏型肥胖小鼠的肝脂肪变性进展。
Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5.
5
Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.高脂饮食诱导肥胖和非酒精性脂肪性肝病小鼠肝脏和脂肪组织中调节脂肪生成的转录因子和基因表达改变。
Eur J Gastroenterol Hepatol. 2008 Sep;20(9):843-54. doi: 10.1097/MEG.0b013e3282f9b203.
6
Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.肝脂肪变性和胰岛素抵抗而非脂肪性肝炎促进非酒精性脂肪性肝病中的致动脉粥样硬化血脂异常。
J Clin Endocrinol Metab. 2016 Feb;101(2):644-52. doi: 10.1210/jc.2015-3111. Epub 2015 Dec 16.
7
Coordinated improvement in glucose tolerance, liver steatosis and obesity-associated inflammation by cannabinoid 1 receptor antagonism in fat Aussie mice.脂肪型 Aussie 小鼠中大麻素 1 型受体拮抗作用对葡萄糖耐量、肝脂肪变性和肥胖相关炎症的协同改善作用。
Int J Obes (Lond). 2011 Dec;35(12):1539-48. doi: 10.1038/ijo.2011.55. Epub 2011 Mar 8.
8
Ultrasonographic and biochemical evaluation of visceral obesity in obese women with non-alcoholic fatty liver disease.非酒精性脂肪性肝病肥胖女性内脏肥胖的超声和生化评估
Eur J Med Res. 2007 Feb 26;12(2):68-73.
9
Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.膳食辣椒素可降低高脂肪饮食诱导肥胖小鼠的肥胖诱导性胰岛素抵抗和肝脂肪变性。
Obesity (Silver Spring). 2010 Apr;18(4):780-7. doi: 10.1038/oby.2009.301. Epub 2009 Oct 1.
10
Liver pathology and the metabolic syndrome X in severe obesity.
J Clin Endocrinol Metab. 1999 May;84(5):1513-7. doi: 10.1210/jcem.84.5.5661.

引用本文的文献

1
Obesity and hypertension.肥胖与高血压。
Exp Ther Med. 2016 Oct;12(4):2395-2399. doi: 10.3892/etm.2016.3667. Epub 2016 Sep 6.
2
Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population.
Dig Dis Sci. 1997 Jul;42(7):1428-32. doi: 10.1023/a:1018850223495.
3
Ampicillin and propylthiouracil pharmacokinetics in intestinal bypass patients followed up to a year after operation.氨苄西林和丙硫氧嘧啶在肠道分流术后随访一年的患者中的药代动力学。

本文引用的文献

1
The liver in obesity.肥胖中的肝脏
AMA Arch Intern Med. 1952 Aug;90(2):141-56. doi: 10.1001/archinte.1952.00240080007002.
2
Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature.脂肪肝:对270例经活检证实为脂肪肝患者的研究及文献综述
Medicine (Baltimore). 1962 Sep;41:249-76. doi: 10.1097/00005792-196209000-00003.
3
SERUM CHOLESTEROL-TRIGLYCERIDE DISTRIBUTION IN A "NORMAL" NEW YORK CITY POPULATION.纽约市“正常”人群的血清胆固醇-甘油三酯分布情况
Clin Pharmacokinet. 1984 Mar-Apr;9(2):168-76. doi: 10.2165/00003088-198409020-00004.
4
Steatosis and cirrhosis in an obese diabetic. Resolution of fatty liver by fasting.肥胖糖尿病患者的脂肪变性和肝硬化。通过禁食使脂肪肝消退。
Dig Dis Sci. 1987 Apr;32(4):441-5. doi: 10.1007/BF01296300.
5
Fatty liver: biochemical and clinical considerations.脂肪肝:生化及临床考量
Am J Dig Dis. 1975 Dec;20(12):1142-70. doi: 10.1007/BF01070758.
Am J Med. 1964 Feb;36:262-8. doi: 10.1016/0002-9343(64)90088-9.
4
Liver impairment in the obese.肥胖人群中的肝脏损害
Gastroenterology. 1958 Apr;34(4):686-93.
5
Surgical treatment of obesity.肥胖症的外科治疗
Am J Surg. 1969 Aug;118(2):141-7. doi: 10.1016/0002-9610(69)90113-5.
6
Serum lipids: an epidemiological study of an active Montreal population.血清脂质:对蒙特利尔活跃人群的一项流行病学研究。
Can Med Assoc J. 1968 Mar 30;98(13):627-37.
7
The results of small intestine bypass operations for the treatment of obesity.小肠旁路手术治疗肥胖症的结果。
Surg Gynecol Obstet. 1971 Jun;132(6):965-79.
8
Lipogranulomas in human liver biopsies with fatty change. A morphological, biochemical and clinical investigation.伴有脂肪变性的人类肝脏活检中的脂肪肉芽肿。一项形态学、生物化学和临床研究。
Acta Pathol Microbiol Scand A. 1971;79(2):150-8. doi: 10.1111/j.1699-0463.1971.tb03323.x.
9
Triglyceride concentrations in primary gout and gout of chronic lead nephropathy.原发性痛风及慢性铅肾病性痛风中的甘油三酯浓度
Metabolism. 1971 Aug;20(8):721-9. doi: 10.1016/s0026-0495(71)80001-x.
10
[Semiologic value of triglyceride determination in fasting obesity and diabetes].[甘油三酯测定在空腹肥胖症和糖尿病中的半定量价值]
Lyon Med. 1971 Feb 14;225(3):201-15.